Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Introducing oncology to undergraduate medical and allied health sciences...

Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India

Introducing oncology to undergraduate medical and allied health sciences students ( Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India )

Low-dose olanzapine after highly emetogenic chemotherapy can be the new...

Dr Jyoti Bajpai - Tata Memorial Centre, Mumbai, India

Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours ( Dr Jyoti Bajpai - Tata Memorial Centre, Mumbai, India )

Cancer care in Needle Hospital, Hargeisa, Somaliland

Gebrekirstos Hagos - Needle Hospital, Hargeisa, Somaliland

Cancer care in Needle Hospital, Hargeisa, Somaliland ( Gebrekirstos Hagos - Needle Hospital, Hargeisa, Somaliland )

Relapsed Refractory Multiple Myeloma

Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India

$Relapsed Refractory Multiple Myeloma ( Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )$

The evolving paradigm in management of Multiple Myeloma

D Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India

The evolving paradigm in management of Multiple Myeloma ( D Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )

First-line chemotherapy with atezolizumab and bevacizumab significantly...

Dr Ana Oaknin - Vall d´Hebron Institute of Oncology, Barcelona, Spain

First-line chemotherapy with atezolizumab and bevacizumab significantly improves survival for R/M cervical cancer ( Dr Ana Oaknin - Vall d´Hebron Institute of Oncology, Barcelona, Spain )

Special issue on real world breast cancer data

Dr Siddhartha Kar - University of Cambridge, Cambridge, UK

Special issue on real world breast cancer data ( Dr Siddhartha Kar - University of Cambridge, Cambridge, UK )

Trial investigates multiparametric prognostic score in early HR+/HER2- breast...

Dr Oleg Gluz - Krankenhaus Bethesda, Mönchengladbach, Germany

Trial investigates multiparametric prognostic score in early HR+/HER2- breast cancer ( Dr Oleg Gluz - Krankenhaus Bethesda, Mönchengladbach, Germany )

Chairperson: Evidence Communication

Dr Hemant Malhotra - Sriram Cancer Center of the Mahatma Gandhi College...

Chairperson: Evidence Communication ( Dr Hemant Malhotra - Sriram Cancer Center of the Mahatma Gandhi College Hospital, Jaipur, India )

Patient benefit vs industry benefit finding a balance

Dr Bishal Gyawali - Queen's University, Kingston, Canada

Patient benefit vs industry benefit finding a balance ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

Haemato-oncological Cancers

Dr Nikita Mehra - Cancer Institute (WIA), Chennai, India

Haemato-oncological Cancers ( Dr Nikita Mehra - Cancer Institute (WIA), Chennai, India )

Hope vs Hype of evidence interpretation

Dr Sanjoy Chatterjee - Tata Medical Center, Kolkata, India

Hope vs Hype of evidence interpretation ( Dr Sanjoy Chatterjee - Tata Medical Center, Kolkata, India )

More from ecancer